AMPICILLIN AND SULBACTAM Drug Patent Profile
✉ Email this page to a colleague
When do Ampicillin And Sulbactam patents expire, and when can generic versions of Ampicillin And Sulbactam launch?
Ampicillin And Sulbactam is a drug marketed by Acs Dobfar, Antibiotice, Astral, Eugia Pharma Speclts, Hikma, Hospira Inc, Hq Speclt Pharma, Istituto Bio Ita Spa, Medimetriks Pharms, Sandoz, and Steriscience Speclts. and is included in twenty-three NDAs.
The generic ingredient in AMPICILLIN AND SULBACTAM is ampicillin sodium; sulbactam sodium. There are seventy drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the ampicillin sodium; sulbactam sodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AMPICILLIN AND SULBACTAM?
- What are the global sales for AMPICILLIN AND SULBACTAM?
- What is Average Wholesale Price for AMPICILLIN AND SULBACTAM?
Summary for AMPICILLIN AND SULBACTAM
| US Patents: | 0 |
| Applicants: | 11 |
| NDAs: | 23 |
| Finished Product Suppliers / Packagers: | 11 |
| Raw Ingredient (Bulk) Api Vendors: | 4 |
| Clinical Trials: | 18 |
| Patent Applications: | 206 |
| DailyMed Link: | AMPICILLIN AND SULBACTAM at DailyMed |
Recent Clinical Trials for AMPICILLIN AND SULBACTAM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Rutgers Robert Wood Johnson Medical School | Phase 4 |
| Assaf-Harofeh Medical Center | Phase 4 |
| Rambam Health Care Campus | Phase 4 |
Pharmacology for AMPICILLIN AND SULBACTAM
| Drug Class | Penicillin-class Antibacterial beta Lactamase Inhibitor |
| Mechanism of Action | beta Lactamase Inhibitors |
US Patents and Regulatory Information for AMPICILLIN AND SULBACTAM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sandoz | AMPICILLIN AND SULBACTAM | ampicillin sodium; sulbactam sodium | INJECTABLE;INJECTION | 065241-002 | Jul 25, 2006 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Medimetriks Pharms | AMPICILLIN AND SULBACTAM | ampicillin sodium; sulbactam sodium | INJECTABLE;INJECTION | 065316-001 | Jun 29, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sandoz | AMPICILLIN AND SULBACTAM | ampicillin sodium; sulbactam sodium | INJECTABLE;INJECTION | 065310-002 | Jul 25, 2006 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Medimetriks Pharms | AMPICILLIN AND SULBACTAM | ampicillin sodium; sulbactam sodium | INJECTABLE;INJECTION | 065316-002 | Jun 29, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Acs Dobfar | AMPICILLIN AND SULBACTAM | ampicillin sodium; sulbactam sodium | INJECTABLE;INJECTION | 065406-001 | Dec 22, 2009 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
